Exchange: NASDAQ·Updated 07:30 PM EDT

HROW News

News
all
press releases
Do Options Traders Know Something About Harrow Stock We Don't?
Investors need to pay close attention to HROW stock based on the movements in the options market lately.
Zacks
Do Options Traders Know Something About Harrow Stock We Don't?
Investors need to pay close attention to HROW stock based on the movements in the options market lately.
Zacks
More News
Harrow's Iheezo Cuts Eye-Injection Discomfort by More Than Half
Harrow (NASDAQ: HROW) posts positive study results for IHEEZO ophthalmic gel, significantly reducing IVT injection patient discomfort.read more...
Benzinga
Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates
Harrow (HROW) delivered earnings and revenue surprises of -47.83% and -0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of +19.23% and -5.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US
Harrow shares gain after relaunching Verkazia in the United States, aiming to improve access to an FDA-approved VKC treatment for pediatric patients.
Zacks
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
Harrow (HROW) delivered earnings and revenue surprises of -48.24% and -12.17%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Zoetis (ZTS) Misses Q1 Earnings and Revenue Estimates
Zoetis (ZTS) delivered earnings and revenue surprises of -5.09% and -1.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates
Relay Therapeutics (RLAY) delivered earnings and revenue surprises of -18.84% and -80.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Harrow (HROW) Projected to Post Quarterly Earnings on Monday
Harrow (NASDAQ:HROW) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at...
MarketBeat
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks

Advertisement|Remove ads.